History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease

Clinical Neurophysiology

Volumn 124, Issue 4, 2013, Pages 697-707

  Kacar A ^a,b   Filipovic S R ^a,b   Kresojevic N ^a,b   Milanovic S D ^a   Ljubisavljevic M ^a,c   Kostic V S ^a,b   Rothwell, J C ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dopaminergic medication; Drug na ve; Excitability; Inhibition; Parkinson's disease; Plasticity; Transcranial magnetic stimulation

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; MOTOR CORTEX; NERVE CELL PLASTICITY; NERVE EXCITABILITY; PAIRED ASSOCIATE LEARNING; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANTIPARKINSON AGENTS; DATA INTERPRETATION, STATISTICAL; DOPAMINE AGENTS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; HAND; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR CORTEX; MUSCLE CONTRACTION; NEURONAL PLASTICITY; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR;

EID: 84875065641     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.09.016     Document Type: Article

References (74)

1. Bagnato S., Agostino R., Modugno N., Quartarone A., Berardelli A. Plasticity of the motor cortex in Parkinson's disease patients on and off therapy. Mov Disord 2006, 21:639-645.
2. Bares M., Kanovsky P., Klajblova H., Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 2003, 10:385-389.
3. Boroojerdi B., Battaglia F., Muellbacher W., Cohen L.G. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001, 112:931-937.
4. Buhmann C., Glauche V., Sturenburg H.J., Oechsner M., Weiller C., Buchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003, 126:451-461.
5. Cantello R., Gianelli M., Bettucci D., Civardi C., De Angelis M.S., Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991, 41:1449-1456.
6. Cantello R., Gianelli M., Civardi C., Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992, 42:1951-1959.
7. Cantello R., Tarletti R., Varrasi C., Cecchin M., Monaco F. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients. Neuroscience 2007, 150:64-71.
8. Cirillo J., Lavender A.P., Ridding M.C., Semmler J.G. Motor cortex plasticity induced by paired associative stimulation is enhanced in physically active individuals. J Physiol 2009, 587:5831-5842.
9. Dauper J., Peschel T., Schrader C., Kohlmetz C., Joppich G., Nager W., et al. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology 2002, 59:700-706.
10. Devanne H., Lavoie B.A., Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res 1997, 114:329-338.
11. Di Lazzaro V., Dileone M., Pilato F., Capone F., Musumeci G., Ranieri F., et al. Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation. J Neurophysiol 2011, 105:2150-2156.
12. Ellaway P.H., Davey N.J., Maskill D.W., Dick J.P. The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroencephalogr clin Neurophysiol 1995, 97:169-178.
13. Fahn S., Elton R.I. Members of the UPDRS development committee. Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 153-163. Macmillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, M. Goldstein, D.B. Calne (Eds.).
14. Filipovic S.R., Papathanasiou I., Whurr R., Rothwell J.C., Jahanshahi M. Differential effect of linguistic and non-linguistic pen-holding tasks on motor cortex excitability. Exp Brain Res 2008, 191:237-246.
15. Fisher R.J., Nakamura Y., Bestmann S., Rothwell J.C., Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 2002, 143:240-248.
16. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" . A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
17. Fuhr P., Agostino R., Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr clin Neurophysiol 1991, 81:257-262.
18. Galvan A., Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol 2008, 119:1459-1474.
19. Gamboa O.L., Antal A., Moliadze V., Paulus W. Simply longer is not better: reversal of theta burst after-effect with prolonged stimulation. Exp Brain Res 2010, 204:181-187.
20. Grafton S.T. Contributions of functional imaging to understanding Parkinsonian symptoms. Curr Opin Neurobiol 2004, 14:715-719.
21. Grosset K., Needleman F., Macphee G., Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004, 19:1370-1374.
22. Hallett M., Chen R., Ziemann U., Cohen L.G. Reorganization in motor cortex in amputees and in normal volunteers after ischemic limb deafferentation. Electroencephalogr Clin Neurophysiol 1999, 51:183-187.
23. Hamada M., Strigaro G., Murase N., Sadnicka A., Galea J.M., Edwards M.J., Rothwell J.C. Cerebellar modulation of human associative plasticity. J Physiol 2012, 590:2365-2374.
24. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001, 124:558-570.
25. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
26. Kishore A., Joseph T., Velayudhan B., Popa T., Meunier S. Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease. Clin Neurophysiol 2012, 123:822-828.
27. Kishore A., Popa T., Velayudhan B., Joseph T., Balachandran A., Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Brain 2012, 135:2074-2088.
28. Kojovic M., Bologna M., Kassavetis P., Murase N., Palomar F.J., Berardelli A., et al. Functional reorganization of sensorimotor cortex in early Parkinson disease. Neurology 2012, 78:1441-1448.
29. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
30. Lefaucheur J.P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005, 116:244-253.
31. Lefaucheur J.P., Drouot X., Von R.F., Menard-Lefaucheur I., Cesaro P., Nguyen J.P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol 2004, 115:2530-2541.
32. MacKinnon C.D., Gilley E.A., Weis-McNulty A., Simuni T. Pathways mediating abnormal intracortical inhibition in Parkinson's disease. Ann Neurol 2005, 58:516-524.
33. Mathis J., De O.D., Hess C.W. Dependence of the transcranially induced silent period on the 'instruction set' and the individual reaction time. Electroencephalogr clin Neurophysiol 1998, 109:426-435.
34. Molina-Luna K., Pekanovic A., Röhrich S., Hertler B., Schubring-Giese M., Rioult-Pedotti M.S., Luft A.R. Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS One 2009, 4:e7082.
35. Morgante F., Espay A.J., Gunraj C., Lang A.E., Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006, 129:1059-1069.
36. Nakashima K., Wang Y., Shimoda M., Sakuma K., Takahashi K. Shortened silent period produced by magnetic cortical stimulation in patients with Parkinson's disease. J Neurol Sci 1995, 130:209-214.
37. Perretti A., De R.A., Marcantonio L., Iodice V., Estraneo A., Manganelli F., et al. Neurophysiological evaluation of motor corticospinal pathways by TMS in idiopathic early-onset Parkinson's disease. Clin Neurophysiol 2011, 122:546-549.
38. Picconi B., Pisani A., Barone I., Bonsi P., Centonze D., Bernardi G., Calabresi P. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology 2005, 26:779-783.
39. Pierantozzi M., Palmieri M.G., Marciani M.G., Bernardi G., Giacomini P., Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 2001, 141:52-62.
40. Popa T, Velayudhan B, Hubsch C, Pradeep S, Roze E, Vidailhet M, Meunier S, Kishore A. Cerebellar processing of sensory inputs primes motor cortex plasticity. Cereb Cortex; in press. doi: . doi:10.1093/cercor/bhs016.
41. Priori A., Berardelli A., Inghilleri M., Accornero N., Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994, 117:317-323.
42. Quartarone A., Bagnato S., Rizzo V., Siebner H.R., Dattola V., Scalfari A., et al. Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain 2003, 126:2586-2596.
43. Quartarone A., Morgante F., Sant'angelo A., Rizzo V., Bagnato S., Terranova C., et al. Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. J Neurol Neurosurg Psychiatry 2008, 79:985-990.
44. Ridding M.C., Inzelberg R., Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995, 37:181-188.
45. Rodriguez-Oroz M.C., Jahanshahi M., Krack P., Litvan I., Macias R., Bezard E., et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009, 8:1128-1139.
46. Rosenkranz K., Rothwell J.C. Differences between the effects of three plasticity inducing protocols on the organization of the human motor cortex. Eur J Neurosci 2006, 23:822-829.
47. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr clin Neurophysiol 1994, 91:79-92.
48. Russmann H., Lamy J.C., Shamim E.A., Meunier S., Hallett M. Associative plasticity in intracortical inhibitory circuits in human motor cortex. Clin Neurophysiol 2009, 120:1204-1212.
49. Sabatini U., Boulanouar K., Fabre N., Martin F., Carel C., Colonnese C., et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000, 123:394-403.
50. Sailer A., Molnar G.F., Paradiso G., Gunraj C.A., Lang A.E., Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 2003, 126:1883-1894.
51. Sale M.V., Ridding M.C., Nordstrom M.A. Factors influencing the magnitude and reproducibility of corticomotor excitability changes induced by paired associative stimulation. Exp Brain Res 2007, 181:615-626.
52. Siebner H.R. A primer on priming the human motor cortex. Clin Neurophysiol 2010, 121:461-463.
53. Siebner H.R., Dressnandt J., Auer C., Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998, 21:1209-1212.
54. Siebner H.R., Mentschel C., Auer C., Conrad B. Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease. Neuroreport 1999, 10:589-594.
55. Stefan K., Kunesch E., Benecke R., Cohen L.G., Classen J. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 2002, 543:699-708.
56. Stefan K., Kunesch E., Cohen L.G., Benecke R., Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 2000, 123:572-584.
57. Strafella A.P., Valzania F., Nassetti S.A., Tropeani A., Bisulli A., Santangelo M., et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol 2000, 111:1198-1202.
58. Suppa A., Marsili L., Belvisi D., Conte A., Iezzi E., Modugno N., et al. Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease. Exp Neurol 2011, 227:296-301.
59. Tergau F., Wanschura V., Canelo M., Wischer S., Wassermann E.M., Ziemann U., et al. Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation. Exp Brain Res 1999, 124:447-454.
60. Tremblay F., Tremblay L.E. Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls. Clin Neurophysiol 2002, 113:2006-2012.
61. Ueki Y., Mima T., Kotb M.A., Sawada H., Saiki H., Ikeda A., et al. Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 2006, 59:60-71.
62. Vacherot F., Attarian S., Eusebio A., Azulay J.P. Excitability of the lower-limb area of the motor cortex in Parkinson's disease. Neurophysiol Clin 2010, 40:201-208.
63. Vacherot F., Attarian S., Vaugoyeau M., Azulay J.P. A motor cortex excitability and gait analysis on Parkinsonian patients. Mov Disord 2010, 25:2747-2755.
64. Valls-Sole J., Pascual-Leone A., Brasil-Neto J.P., Cammarota A., McShane L., Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology 1994, 44:735-741.
65. Ward C.D., Gibb W.R. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990, 53:245-249.
66. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 1999, 517:591-597.
67. Wilder J. The law of initial value in neurology and psychiatry; facts and problems. J Nerv Ment Dis 1957, 125:73-86.
68. Wilson S.A., Lockwood R.J., Thickbroom G.W., Mastaglia F.L. The muscle silent period following transcranial magnetic cortical stimulation. J Neurol Sci 1993, 114:216-222.
69. Wolters A., Sandbrink F., Schlottmann A., Kunesch E., Stefan K., Cohen L.G., et al. A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol 2003, 89:2339-2345.
70. Wu A.D., Petzinger G.M., Lin C.H., Kung M., Fisher B. Asymmetric corticomotor excitability correlations in early Parkinson's disease. Mov Disord 2007, 22:1587-1593.
71. Zamir O., Gunraj C., Ni Z., Mazzella F., Chen R. Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease. Clin Neurophysiol 2012, 123:815-821.
72. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
73. Ziemann U., Rothwell J.C., Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996, 496:873-881.
74. Ziemann U., Siebner H.R. Modifying motor learning through gating and homeostatic metaplasticity. Brain Stimulat 2008, 1:60-66.